News
Plaque radiotherapy is the most common conservative treatment for uveal melanoma. This therapy has been custom-adapted f…
Joel Pakett, BS; Michele D. Markovitz, BA; Sruthi Arepalli, BA; and Carol L. Shields, MD
These articles are based on the debate-style presentations at the American Academy of Ophthalmology Retina Subspecialty …
Tarek S. Hassan, MD and Julia A. Haller, MD
Facedown positioning for 3 days to 1 week after surgery for idiopathic macular hole repair remains the traditional stand…
Raymond Iezzi, MD, MS
Proliferative diabetic retinopathy is a major cause of visual impairment and blindness among people with diabetes in dev…
Ken Y. Lin, MD, PhD; and Stephanie Y. Lu, MD
Laser photocoagulation is a proven treatment for retinal pathologies and has been used for more than 60 years to treat a…
Sebastien Guigou, MD
This pseudophakic patient underwent Ozurdex injection for posterior uveitis several weeks prior to presenting with compl…
Valli Muthappan, MD, Majid Moshirfar MD
Shlomit Schaal, MD, PhD, and Niloofar Piri, MD, present 25G vitrectomy surgery for an intermediate chronic uveitis of un…
Niloofar Piri, MD, Shlomit Schaal, MD, PhD
Michael Singer, MD, and Joshua Singer of the Medical Center Ophthalmology Associates in San Antonio, Texas demonstrates …
Michael Singer MD
Removal of Ozurdex from Anterior Chamber of Pseudophakic Pat…
25G Vitrectomy for the Treatment of Chronic Intermediate Uve…
Ozurdex 2.0: The Game Has Changed
